New Neuron Structure May Be Key to Treating Alzheimer’s Disease

A Cellular Gatekeeper Unmasked

Penn State researchers have identified a specialized protein lattice within neurons, the membrane-associated periodic skeleton (MPS), that acts as a vital gatekeeper for cellular nutrient uptake. Published in Science Advances, the study reveals that this structure regulates endocytosis—the process by which cells internalize molecules. Crucially, the MPS may play a critical role in preventing the toxic protein accumulation associated with neurodegenerative conditions like Alzheimer’s disease.

Nanoscale Regulation of Endocytosis

For years, scientists viewed the MPS primarily as a passive structural support meant to maintain the shape of neurons. That perspective has shifted. Led by Ruobo Zhou, an assistant professor of chemistry, of biochemistry and molecular biology, and of biomedical engineering at Penn State, the team utilized super-resolution microscopy to observe neurons at the nanoscale.

They discovered the lattice, composed of repeating protein rings, is a physical regulator. It controls the timing and location of substance entry into the cell, preventing neurons from absorbing excessive nutrients or extracellular material. When researchers disrupted this lattice in laboratory-grown neurons, endocytosis accelerated, confirming the structure functions as a throttle for cellular uptake.

The Cycle of Structural Degradation

The study highlights a complex feedback loop between nutrient uptake and skeletal integrity. When endocytosis occurs too rapidly, the MPS weakens. This structural degradation triggers molecular signals that further dismantle the lattice, creating a cycle that allows an influx of proteins and nutrients.

This pathway is significant because endocytosis is how neurons internalize amyloid precursor protein (APP). Under normal conditions, the MPS limits APP intake. Its breakdown removes this protective barrier.

Linking APP to Alzheimer’s Pathology

The team modeled early-stage Alzheimer’s by inducing high levels of APP in neurons. They found that when the MPS was weakened, neurons rapidly internalized APP. Once inside, this protein was processed into amyloid-B42, a toxic fragment linked to the development of the disease.

“We created a model which is very much like Alzheimer’s disease and found that in some aging neurons, or neurons under pathologic conditions, the endocytosis of toxic proteins was enhanced, which caused stressing conditions, ultimately leading to neuron deaths,” said Jinyu Fei, the study’s lead author and a graduate student in the chemistry department in Penn State’s Eberly College of Science.

Stabilization as a Therapeutic Target

The discovery offers a potential new target for medical intervention. Because the lattice deteriorates during the aging process and in the presence of neurodegenerative disease, stabilizing it could theoretically slow cell death.

“Preserving or stabilizing the MPS might offer a way to slow the early, hidden cellular changes that precede Alzheimer’s symptoms,” Fei noted. The research team, which included Yuanmin Zheng, Caden LaLonde, and Yuan Tao, was supported by funding from the National Institutes of Health.

Core Findings

• The MPS Role: Previously thought to be a passive support system, the membrane-associated periodic skeleton (MPS) is a dynamic gatekeeper that regulates nutrient uptake in neurons.
• Disease Connection: The breakdown of the MPS accelerates the intake of amyloid precursor protein (APP), which is a key precursor to the toxic amyloid-B42 fragments found in Alzheimer’s patients.
• Feedback Loops: Excessive endocytosis weakens the MPS, which in turn triggers further degradation of the lattice, creating a cycle that leaves neurons vulnerable.
• Therapeutic Outlook: Future treatments aimed at stabilizing the MPS could potentially slow the early cellular damage associated with neurodegenerative diseases.